drugset / Trial / NCT04083625

the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy

NCT04083625

Phase 4 Completed 138 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To investigate the effectiveness of carbetocin on reducing intraoperative blood loss during abdominal myomectomy

Timeline

Start
2019-09-10
Primary completion
2020-02-10
Completion
2020-02-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbetocin Peptide 100 ug Intravenous

Indications